These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21686214)

  • 21. The implications of vaccines for prevention of bacterial meningitis.
    Riordan A
    Curr Opin Neurol; 2010 Jun; 23(3):319-24. PubMed ID: 20173637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination in Southeast Asia--reducing meningitis, sepsis and pneumonia with new and existing vaccines.
    Richardson A; Morris DE; Clarke SC
    Vaccine; 2014 Jul; 32(33):4119-23. PubMed ID: 24907487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis.
    Greenwood BM
    Rev Infect Dis; 1984; 6(3):374-89. PubMed ID: 6429812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.
    Campagne G; Garba A; Fabre P; Schuchat A; Ryall R; Boulanger D; Bybel M; Carlone G; Briantais P; Ivanoff B; Xerri B; Chippaux JP
    Pediatr Infect Dis J; 2000 Feb; 19(2):144-50. PubMed ID: 10694002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustaining immunity after immunization against encapsulated bacteria.
    Blanchard-Rohner G; Pollard AJ
    Hum Vaccin; 2008; 4(4):309-12. PubMed ID: 18398302
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Slack M; Esposito S; Haas H; Mihalyi A; Nissen M; Mukherjee P; Harrington L
    Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease.
    Molrine DC; George S; Tarbell N; Mauch P; Diller L; Neuberg D; Shamberger RC; Anderson EL; Phillips NR; Kinsella K; Ambrosino DM
    Ann Intern Med; 1995 Dec; 123(11):828-34. PubMed ID: 7486464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Haemophilus influenzae type b vaccines on the epidemiology of bacterial meningitis.
    Wenger JD
    Infect Agents Dis; 1993 Oct; 2(5):324-32. PubMed ID: 8173815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccines against bacterial meningitis.
    Segal S; Pollard AJ
    Br Med Bull; 2004; 72():65-81. PubMed ID: 15802609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction of Haemophilus influenzae type B conjugate vaccine into routine immunization in Ghana and its impact on bacterial meningitis in children younger than five years.
    Renner LA; Newman MJ; Ahadzie L; Antwi-Agyei KO; Eshetu M
    Pediatr Infect Dis J; 2007 Apr; 26(4):356-8. PubMed ID: 17414404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines.
    Sanneh B; Okoi C; Grey-Johnson M; Bah-Camara H; Kunta Fofana B; Baldeh I; Papa Sey A; Labbo Bah M; Cham M; Samateh A; Usuf E; Ndow PS; Senghore M; Worwui A; Mwenda JM; Kwambana-Adams B; Antonio M
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S126-S132. PubMed ID: 31505634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Streptococcus pneumoniae and Haemophilus influenzae in paediatric meningitis patients at Goroka General Hospital, Papua New Guinea: serotype distribution and antimicrobial susceptibility in the pre-vaccine era.
    Greenhill AR; Phuanukoonnon S; Michael A; Yoannes M; Orami T; Smith H; Murphy D; Blyth C; Reeder J; Siba P; Pomat W; Lehmann D
    BMC Infect Dis; 2015 Oct; 15():485. PubMed ID: 26521138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial.
    Safadi MAP; Martinon-Torres F; Weckx LY; Moreira ED; da Fonseca Lima EJ; Willemsen A; Toneatto D; Habib MA; Borys D
    Vaccine; 2019 Aug; 37(35):4858-4863. PubMed ID: 31327652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Conjugated vaccines].
    Swennen B; Sternon J
    Rev Med Brux; 2002 Jun; 23(3):165-74. PubMed ID: 12143156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination conjugate vaccines.
    Bar-Zeev N; Buttery JP
    Expert Opin Drug Saf; 2006 May; 5(3):351-60. PubMed ID: 16610965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.
    Soriano-Gabarró M; Rosenstein N; LaForce FM
    J Health Popul Nutr; 2004 Sep; 22(3):275-85. PubMed ID: 15609780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Meningitis Vaccine Project.
    LaForce FM; Konde K; Viviani S; Préziosi MP
    Vaccine; 2007 Sep; 25 Suppl 1():A97-100. PubMed ID: 17521780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of carrier proteins on vaccine-induced immune response.
    Knuf M; Kowalzik F; Kieninger D
    Vaccine; 2011 Jul; 29(31):4881-90. PubMed ID: 21549783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbohydrate-protein conjugate vaccines.
    Ada G; Isaacs D
    Clin Microbiol Infect; 2003 Feb; 9(2):79-85. PubMed ID: 12588327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Suppurative bacterial meningitis and the outlook for specific prevention].
    Demina AA; Deviatkina NP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):3-10. PubMed ID: 6429984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.